PTN · XBRL financial data
Palatin Technologies financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (PTN's year ends in late June)
| In thousands of dollars | Jun 30, 2021 | †Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 | †Jun 30, 2025 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Revenue | (189) | 1,468 | 4,854 | 4,490 | 0 | 8,830 |
| Revenue from contracts with customers | — | — | — | — | — | 13,185 |
| Cost of revenue | 148 | 218 | 418 | 98 | — | — |
| Research and development | 12,927 | 21,327 | 22,631 | 22,400 | 14,898 | 12,369 |
| Selling, general and administrative | — | 16,512 | 15,291 | 12,270 | 7,809 | — |
| General and administrative | 17,337 | 16,512 | — | — | 7,809 | 9,484 |
| Total operating expenses | 33,196 | 38,057 | 37,313 | 26,986 | 17,460 | 21,853 |
| Operating income (loss) | (33,384) | (36,588) | (32,459) | (22,496) | (17,460) | (8,668) |
| Interest income | 24 | — | — | — | — | — |
| Interest expense | 23 | 30 | 20 | 17 | 15 | 7 |
| Other income (expense) | — | 390 | 242 | (7,240) | 153 | 290 |
| Income tax expense (benefit) | — | 0 | 4,675 | 0 | (17,307) | (8,378) |
| Net income (loss) | (33,596) | (36,198) | (27,542) | (29,736) | (17,307) | (8,378) |
| Earnings per share, basic USD per share | — | — | (2.21) | (2.02) | (32.15) | (2.96) |
| Earnings per share, diluted USD per share | — | — | — | (101.16) | (32.15) | (2.96) |
| Weighted average shares, basic thousands of shares | — | — | 10,890 | 14,697 | 538 | 2,827 |
| Weighted average shares, diluted thousands of shares | — | — | — | 294 | 538 | 2,827 |
- † Share count changed about 1/25 in the period ending 2022-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/20 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (PTN's year ends in late June)
| In thousands of dollars | Jun 30, 2021 | †Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 | †Jun 30, 2025 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 60,105 | 29,939 | 10,982 | 9,527 | 2,564 | 7,492 |
| Marketable securities | — | 0 | 2,993 | 0 | — | — |
| Accounts receivable | 1,580 | 1,780 | 2,916 | 0 | 0 | 301 |
| Inventory | 1,162 | 944 | 526 | 0 | — | — |
| Prepaid and other current assets | 3,060 | 1,932 | 1,897 | 242 | 326 | 372 |
| Total current assets | 65,907 | 34,596 | 16,322 | 9,770 | 2,919 | 8,164 |
| Property and equipment, net | 95 | 539 | 685 | 388 | 129 | 118 |
| Right-of-use asset | 1,238 | 878 | 876 | 527 | 161 | 220 |
| Total assets | 67,297 | 36,071 | 17,939 | 10,742 | 3,267 | 8,524 |
| Accounts payable | 641 | 3,158 | 4,304 | 4,102 | 6,999 | 1,110 |
| Accrued liabilities | 5,797 | 6,875 | 6,511 | 4,185 | 881 | 504 |
| Total current liabilities | 10,512 | 16,260 | 15,132 | 9,658 | 8,010 | 1,772 |
| Lease liability, non-current | 901 | 529 | 544 | 164 | 34 | 65 |
| Total liabilities | 17,645 | 19,803 | 17,805 | 10,854 | 8,044 | 1,837 |
| Accumulated deficit | (351,795) | (387,994) | (415,536) | (441,767) | (459,074) | (467,452) |
| Total stockholders' equity | 49,651 | 16,268 | 134 | (111) | (4,777) | 6,686 |
| Total liabilities and equity | 67,297 | 36,071 | 17,939 | 10,742 | 3,267 | 8,524 |
| Common shares outstanding (cover page) thousands of shares | 231,258 | 9,290 | 11,947 | 19,548 | 973 | 1,781 |
- † Share count changed about 1/25 in the period ending 2022-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/20 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (PTN's year ends in late June)
| In thousands of dollars | Jun 30, 2021 | †Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 | †Jun 30, 2025 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Net income (loss) | (33,596) | (36,198) | (27,542) | (29,736) | (17,307) | (8,378) |
| Stock-based compensation | 3,169 | 2,506 | 1,411 | 1,873 | 1,382 | 1,329 |
| Depreciation and amortization | 51 | 127 | — | — | — | — |
| Net cash from operating activities | (22,648) | 18 | (28,419) | (31,461) | (21,307) | (13,533) |
| Purchases of property and equipment | 6 | 261 | 434 | 43 | 0 | 51 |
| Net cash from investing activities | (6) | (261) | (3,427) | 12,450 | 3,130 | (51) |
| Proceeds from issuing common stock | — | 0 | 10,143 | 14,666 | 7,961 | 16,911 |
| Proceeds from issuing equity | 0 | — | — | — | — | — |
| Net cash from financing activities | (94) | (29,923) | 9,896 | 20,549 | 11,214 | 18,512 |
- † Share count changed about 1/25 in the period ending 2022-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/20 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Palatin Technologies | 7,492 | 301* | (2,690)* | 1.8M | 2.8 quarters | 10-KJun 30, 2026 |
| Scynexis | 10,487 | 235 | (14,885)* | 9.9M | 3.6 quarters | 10-QJun 30, 2026 |
| Pulmatrix | 2,168 | not reported | (1,106)* | 3.7M | 2.0 quarters | 10-QJun 30, 2026 |
| Curis | 5,073 | 0 | (9,646)* | 2.1M | 0.5 quarters | 10-QJun 30, 2026 |
| Kala Bio | 229 | not reported | (1,535)* | 19.3M | 4.7 quarters | 10-QJun 30, 2026 |
| Lexaria Bioscience | 3,500 | 0 | (1,635)* | 24.8M | 2.2 quarters | 10-QMay 31, 2026 |
| Outlook Therapeutics | 11,242 | not reported | (21,011)* | 243.4M | 0.5 quarters | 10-QJun 30, 2026 |
| Dyadic International | 1,425 | 961 | (1,818)* | 36.4M | 1.7 quarters | 10-QJun 30, 2026 |
| Aytu Biopharma | 26,308 | 16,106* | 4,406* | 10.9M | — | 10-KJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.